Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review-Reference-Cited by-同舟云学术

Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review

Published:2022-09-09 Issue:10 Volume:60 Page:854-861
ISSN:1362-4393
Container-title:Spinal Cord
language:en
Short-container-title:Spinal Cord

Author:

Akkoc Yesim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.nature.com/articles/s41393-022-00853-3.pdf

Reference32 articles.

1. Fowler CJ, Dalton C, Panicker JN. Review of neurologic diseases for the urologist. Urol Clin North Am. 2010;37:517–26.

2. Mete UK, Powell CR. Review of current neurogenic bladder best practices and international guidelines. Curr Bladder Dysfunct Rep. 2020;15:283–95.

3. Cooley LF, Kielb S. A review of botulinum toxin a for the treatment of neurogenic bladder. Pmr. 2019;11:192–200.

4. Kashyap M, Tyagi P. The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option. Expert Opin Drug Metab Toxicol. 2013;9:617–27.

5. El Helou E, Labaki C, Chebel R, El Helou J, Abi Tayeh G, Jalkh G, et al. The use of mirabegron in neurogenic bladder: a systematic review. World J Urol. 2020;38:2435–42.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An individual participant meta‐analysis of mirabegron in multiple sclerosis and spinal cord injury;Neurourology and Urodynamics;2024-03-13

2. Unmet needs in the management of neurourological disorders within the last 50 years;World Journal of Urology;2023-11-02

3. Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies;Current Neurology and Neuroscience Reports;2023-07-31

4. Clinical Guidelines of Patient-Centered Bladder Management of Neurogenic Lower Urinary Tract Dysfunction due to Chronic Spinal Cord Injury - Part 2;Urological Science;2023-01

5. A Randomized Study of b3 Agonists versus Anticholinergics Administration in Patients with Multiple Sclerosis and Lower Urinary Tract Dysfunction;Hellenic Urology;2022-10